Home -> Law Blog Directory -> Qui Tam Blogs -> Pharma 101 - Pharmaceutical Fraud
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Qui Tam
: Pharma 101 - Pharmaceutical FraudAventis Aware of Fraudulent Data Regarding Ketek Says CRO Employee
By Kenneth Nolan
A former staff member of the Pharmaceutical Product Development (PPD) has claimed that Aventis and PPD - the contract research organization (CRO) hired by Aventis- both knew of fraudulent data in a postmarketing trial for the antibiotic drug during a testimony before a US Congressional subcommittee last week.
The postmarketing study was carried out between November 2001 and March 2002 on behalf of Aventis by PPD, after the FDA required more safety information on Ketek following concerns that it could cause liver problems.
The study was allegedly riddled with fraud, including unscrupulous patient recruitment by some of the enrolling doctors and significant under reporting of adverse events.
To read more about CRO fraud and how it can result in a violation of the False Claims Act, click here.
No TagsFull post as published by Pharma 101 - Pharmaceutical Fraud on February 22, 2007 (boomark / email).
Employee Lawsuits (An Introduction and Topic Overview)
How employers can cope with the siege of employee lawsuits
Employee Lawsuits: Negligent Hiring and Retention
Employers must check references, criminal records, other background material.
Electronic Data Systems Corp.
allegedly failed to pay employee overtime.
Ketek
allegedly causing potentially life threatening Stevens Johnson Syndrome (SJS) skin reaction.
Anzemet Pricing
Aventis Pharmaceuticals Inc. agrees to $22.7 million settlement for inflating drug prices.
KeyBank USA
alleging the bank offered loans for fraudulent vocational schools.
H&R Block Reaches Multi-Million Dollar Settlement Over Fraudulent IRAs
H&R Block Reaches Multi-Million Dollar Settlement Over Fraudulent IRAs
Stephen J. Hyland
alleging fraudulent operations in offering expertise in same gender couples' issues.

Aventis Pharma S.A. v. Amphastar Pharmaceuticals (Fed. Cir. 2008)
EU Antitrust Powers Not Enough for Dawn Raid
Prior Art Must Enable a Skilled Artisan to Make the Invention without Undue Experimentation
Inequitable Conduct: Failure to Submit Full Experimental Details








